Add like
Add dislike
Add to saved papers

Preoperative and histological predictors of recurrence and survival in atypical meningioma after initial gross total resection.

World Neurosurgery 2019 April 15
OBJECTIVE: Atypical (WHO grade II) meningiomas (AM) are associated with a substantial risk for recurrence even following a complete, gross total resection (GTR). The present study aimed to evaluate clinical and AM tumor histopathological features that may predict risk of recurrence and survival within this patient population.

METHODS: 72 consecutive patients and corresponding tumor specimens who received a primary GTR for an AM from 2007-2016 at a single institution were reviewed. Preoperative patient and tumor characteristics were correlated with post-resection outcomes including recurrence and 1-year survival. Cox regression models on recurrence-free survival (RFS) and Kaplan-Meier survival estimates were performed.

RESULTS: Overall 1, 3, and 5-year RFS estimates for the AM cohort were 100.0, 82.4, and 78.1%, respectively post-resection. High mitotic index was found to be an independent predictor of RFS on Cox regression analysis (HR=1.26, p=0.008), while tumor volume trended towards a significant association (HR=0.93, p=0.079). Age and mitotic index were significantly associated with 1-year mortality (OR=1.11 and 1.36, p=0.028 and 0.045, respectively).

CONCLUSIONS: AM tumors with a high proliferative index increased the likelihood of recurrence and short-term survival even after complete resection. Smaller tumor volume may also contribute to an increased risk of recurrence within AM patients. While other histopathological features were not linked to recurrence or mortality within AM patients, biopsy examination can indicate key predictive information, and further molecular analysis may reveal additional prognostic markers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app